| Clinical data | |
|---|---|
| Other names | GSK3228836 |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| UNII | |
Bepirovirsen (GSK3228836) is an antisense oligonucleotide developed to treat hepatitis B infection. [1]
References
- ^ Mak, Lung-Yi; Hui, Rex Wan-Hin; Fung, James; Seto, Wai-Kay; Yuen, Man-Fung (2 November 2023). "Bepirovirsen (GSK3228836) in chronic hepatitis B infection: an evaluation of phase II progress". Expert Opinion on Investigational Drugs. 32 (11): 971–983. doi: 10.1080/13543784.2023.2277389. PMID 37902953. S2CID 264672407.